Physician profile
Michelle Coriddi
NPI 1720375850
$2,103.60
in general payments reported to CMS, 2019-2025
10 companies · $306 in 2025
The $306 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $586 · 2022: $353 · 2023: $516 · 2024: $342 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,156 · Gift: $8.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,155.90 |
| Gift | $8.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $585.76 | 2021 | |
| Abbvie INC. | $438.84 | 2023-2024 | Alloderm |
| Rti Surgical, INC | $351.94 | 2024-2025 | |
| Integra Lifesciences Corporation | $299.92 | 2022 | |
| Axogen | $161.39 | 2023 | Avance Nerve Graft |
| Kerecis Limited | $151.22 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Depuy Synthes Sales INC. | $52.51 | 2023 | Trumatch |
| Allergan, INC. | $26.80 | 2022 | |
| Medical Device Business Services, INC. | $26.60 | 2022 | |
| 3d Systems | $8.62 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Coriddi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.